Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Increase in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) was the recipient of a large increase in short interest in July. As of July 15th, there was short interest totaling 22,725 shares, an increase of 67.9% from the June 30th total of 13,534 shares. Approximately 2.1% of the shares of the stock are short sold. Based on an average daily volume of 7,171 shares, the days-to-cover ratio is currently 3.2 days.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in Global X HealthTech ETF in the third quarter worth about $274,000. Flow Traders U.S. LLC acquired a new stake in Global X HealthTech ETF in the 3rd quarter valued at about $368,000. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at about $11,239,000. Citadel Advisors LLC bought a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at about $216,000. Finally, Banque Cantonale Vaudoise acquired a new position in shares of Global X HealthTech ETF in the 3rd quarter worth approximately $37,000.

Global X HealthTech ETF Stock Performance

Shares of HEAL stock opened at $26.78 on Friday. Global X HealthTech ETF has a 1 year low of $23.00 and a 1 year high of $33.59. The stock has a market cap of $28.39 million, a PE ratio of 42.80 and a beta of 1.10. The business’s fifty day moving average is $26.76 and its 200-day moving average is $26.33.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.